Immutep (IMMP) Research & Development (2015 - 2017)
Immutep (IMMP) posted Research & Development of $9.1 million for Q2 2017, up 758.25% on a QoQ basis from -$1.4 million in Q1 2017, and down 3.54% year-over-year from $9.4 million in Q2 2016.
Immutep (IMMP) Research & Development (2015 - 2017) Analysis & Trends
Immutep's Research & Development history runs 3 years deep, the most recent figure standing at $9.1 million for Q2 2017.
- Quarterly Research & Development fell 3.54% year-over-year to $9.1 million in Q2 2017, while the trailing twelve-month figure through Jun 2017 was $16.0 million (changed N/A YoY) and the FY2020 annual result came in at $13.4 million, up 15.03% from the prior year.
- Research & Development was $9.1 million for Q2 2017 at Immutep, up from -$1.4 million in the prior quarter.
- Across five years, Research & Development topped out at $9.4 million in Q2 2016 and bottomed at -$3.8 billion in Q2 2015.
- A 3-year average of -$757.4 million and a median of -$1.1 million in 2016 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2016 — Research & Development soared 100.25% — and 2017, when it retreated 27.11%.
- Immutep's Research & Development stood at -$3.8 billion in 2015, then surged by 100.25% to $9.4 million in 2016, then fell by 3.54% to $9.1 million in 2017.
- Business Quant data shows IMMP's Research & Development at $9.1 million in Q2 2017, -$1.4 million in Q1 2017, and $9.4 million in Q2 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -17.94 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 1.46 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 541.22 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 961.60 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 1.54 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 15.66 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -443.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 343.97 Mn |
| 10 | Immutep | 569.08 Mn | 569.08 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2017 | 9.05 Mn |
| Mar 31, 2017 | -1.38 Mn |
| Jun 30, 2016 | 9.38 Mn |
| Mar 31, 2016 | -1.08 Mn |
| Jun 30, 2015 | -3.80 Bn |